1-3 of 3
Rebecca K.M. Protheroe
Close
Sort by
Journal Articles

Gain of 1q21 Does Not Predict for Immediate Progression in MGUS.

Laura Chiecchio, Gian Paolo Dagrada, Elizabet Dachs Cabanas, Rebecca K.M. Protheroe, David M. Stockley, Zoe J. Konn, Nicholas C.P. Cross, Christine J. Harrison, Fiona M. Ross
Journal: Blood
Blood (2009) 114 (22): 123.
https://doi.org/10.1182/blood.V114.22.123.123
Published: 2009
Journal Articles

Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD .

Matthew W. Jenner, MD, Paola E. Leone, PhD, Brian A. Walker, PhD, David C. Johnson, BSc, Laura Chiecchio, MSc, Elisabet Dachs Cabanas, BSc, Gian Paolo Dagrada, MSc, Mathew Nightingale, Rebecca K.M. Protheroe, BSc, David Stockley, BSc, Monica Else, MSc, Fiona M. Ross, PhD, Nicholas C.P. Cross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 110.
https://doi.org/10.1182/blood.V108.11.110.110
Published: 2006
Journal Articles

Critical Importance of Conventional Cytogenetics in Detecting Prognostically Significant Chromosome 13 Deletions in Myeloma.

Laura Chiecchio, MBS, Rebecca K.M. Protheroe, BSc, Tim Parker, BSc, Christina Rudduck, PhD, Kan Luk Cheung, BSc, Gianpaolo Dagrada, MBS, Ashutosh Wechalekar, MD, Mathew Nightingale, BSc, Christine J. Harrison, PhD, Nicholas C.P. Cross, PhD, Fiona M. Ross, DPhil
Journal: Blood
Blood (2005) 106 (11): 1544.
https://doi.org/10.1182/blood.V106.11.1544.1544
Published: 2005